Passage Bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Cash & Equivalents	21.71	34.6	128.97	135	158.87	24.86
Short-Term Investments	92.59	155.01	186.81	169.82	0	0
Cash & Cash Equivalents	114.29	189.61	315.77	304.82	158.87	24.86
Cash Growth	-39.72%	-39.95%	3.59%	91.86%	539.05%	-
Other Current Assets	3.67	7.43	9.29	12.37	6.9	8.54
Total Current Assets	117.96	197.04	325.07	317.18	165.78	33.4
Property, Plant & Equipment	32.15	42.24	23.81	2.8	1.09	0.03
Other Long-Term Assets	0.43	4.27	6.2	8.03	11.75	0.03
Total Long-Term Assets	32.59	46.51	30.01	10.82	12.84	0.06
Total Assets	150.55	243.55	355.08	328.01	178.61	33.46
Accounts Payable	1.3	4.07	9.45	5.27	0.63	0.21
Current Debt	3.37	3.28	0	0	0	0
Other Current Liabilities	11.67	11.01	20.05	15.91	3.05	0.1
Total Current Liabilities	16.34	18.35	29.5	21.18	3.68	0.31
Long-Term Debt	22.92	23.83	0	0	0	0
Other Long-Term Liabilities	0	0	6.92	2.12	0.58	2.21
Total Long-Term Liabilities	22.92	23.83	6.92	2.12	0.58	2.21
Total Liabilities	39.26	42.18	36.42	23.29	4.26	2.52
Total Debt	26.29	27.11	0	0	0	0
Debt Growth	-3.00%	-	-	-	-	-
Retained Earnings	-594.47	-492.41	-356.28	-170.9	-58.66	-13.03
Comprehensive Income	-0.04	-0.97	-0.41	-0.01	0	0
Shareholders' Equity	111.28	201.37	318.66	304.71	-56.25	-12.17
Net Cash / Debt	88	162.5	315.77	304.82	158.87	24.86
Net Cash / Debt Growth	-45.85%	-48.54%	3.59%	91.86%	539.05%	-
Net Cash Per Share	1.61	2.99	5.92	7.89	37.51	6.91
Working Capital	101.62	178.69	295.57	296.01	162.09	33.09
Book Value Per Share	2.03	3.70	5.97	7.89	-13.28	-3.38

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).